NCT00384215View on ClinicalTrials.gov

Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin

PHASE4CompletedINTERVENTIONAL
Enrollment

352

Participants

Timeline

Start Date

December 31, 2001

Study Completion Date

February 28, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

insulin glargine [rDNA origin] injection

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY